Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stabilisation of vaccines using trehalose (Q-T4) technology

E M Gribbon1, S D Sen, B J Roser

  • 1Quadrant Holdings Cambridge Limited, Vaccine Division, England.

Developments in Biological Standardization
|January 1, 1996
PubMed
Summary

Trehalose stabilization offers a cost-effective solution for enhancing vaccine stability across all vaccine types. This technology can revolutionize vaccine manufacturing and enable new delivery formats and combinations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single expression of CD45RC and RT6 in correlation with T-helper 1 and T-helper 2 cytokine patterns in the rat.

Cellular immunology·2000
Same author

Post-thymic T-cell development in the rat.

Thymus·1997
Same author

Susceptibility to clinically manifest cyclosporine A (CsA)-induced autoimmune disease is associated with interferon-gamma (IFN-gamma)-producing CD45RC+RT6- T helper cells.

Clinical and experimental immunology·1996
Same author

Abnormal thymocyte subset distribution and differential reduction of CD4+ and CD8+ T cell subsets during peripheral maturation in diabetes-prone BioBreeding rats.

Journal of immunology (Baltimore, Md. : 1950)·1996
Same author

Simultaneous transplantation and intrathymic tolerance induction. A method with clinical potential.

Transplantation·1995
Same author

High-frequency, but reduced absolute numbers of recent thymic migrants among peripheral blood T lymphocytes in diabetes-prone BB rats.

Cellular immunology·1995

Area of Science:

  • Biotechnology
  • Pharmaceutical Sciences
  • Vaccinology

Background:

  • Vaccine stability is a critical challenge in manufacturing and distribution.
  • Current stabilization methods can be costly and complex.
  • There is a need for universally applicable and affordable stabilization technologies.

Purpose of the Study:

  • To investigate the efficacy of trehalose as a universal vaccine stabilization technology.
  • To assess the cost-effectiveness of trehalose-based stabilization.
  • To explore the potential of trehalose in enabling novel vaccine formats.

Main Methods:

  • Utilized trehalose as a cryoprotectant and lyoprotectant for various vaccine candidates.
  • Evaluated vaccine stability under different storage conditions (e.g., temperature, humidity).

Related Experiment Videos

  • Assessed the feasibility of incorporating trehalose into novel vaccine delivery systems.

    • Main Results:

    • Trehalose demonstrated significant stabilization effects across diverse vaccine types.
    • The trehalose stabilization method proved to be cost-effective compared to existing technologies.
    • The study identified potential for new vaccine formulations and combination therapies using trehalose.

    Conclusions:

    • Trehalose is a promising, cost-effective, and broadly applicable technology for improving vaccine stability.
    • This approach has the potential to significantly impact modern vaccine manufacturing processes.
    • The findings open avenues for developing innovative vaccine delivery methods and combinations.